Pegvisomant (Subcutaneous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Pegvisomant (Subcutaneous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Somavert

Description

Pegvisomant is used to treat a condition called acromegaly, which is caused by too much growth hormone in the body, in patients who cannot be treated with surgery or radiation. Too much growth hormone produced in adults causes the hands, feet, and parts of the face to become large, thick, and bulky. Other problems such as arthritis also can develop. Pegvisomant works by binding to the growth hormone receptor and preventing the actions of too much growth hormone .

This medicine is available only with your doctor's prescription.

Before Using
DR601735 Portions of this document last updated: Nov. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger